The Plasma Protein Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Plasma Protein Therapeutics Market?
The market size of plasma protein therapeutics has seen significant growth lately. The market will expand from $31.86 billion in 2024 to $34.55 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Plasma Protein Therapeutics Industry?
The Plasma Protein Therapeutics market is projected to grow to $46.35 billion in 2029, with a compound annual growth rate (CAGR) of 7.6%.
Download Your Free Sample of the 2025 Plasma Protein Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Plasma Protein Therapeutics Market?
The key drivers in the plasma protein therapeutics market are:
• Advancements in gene therapy
• Increase in healthcare expenditure
• Expansion of therapeutic indications
• Adoption of precision medicine approaches
Global Market Segmentation: Identifying Major Plasma Protein Therapeutics Industry Segments
The plasma protein therapeutics market covered in this report is segmented –
1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications
Pre-order the 2025 Plasma Protein Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Plasma Protein Therapeutics Market?
The key trends in the plasma protein therapeutics market are:
• Technological innovations and advancements in plasma fractionation are driving trends in the market.
• The increased adoption of telemedicine is shaping the future of the plasma protein therapeutics market.
• The development of next-generation therapies is a significant emerging trend.
• The trend towards personalized medicine and recombinant therapies is also influencing the market.
Who Are the Top Competitors & Leading Players in the Plasma Protein Therapeutics Market?
Major companies in the plasma protein therapeutics market are:
• CSL Behring LLC
• Grifols SA
• China Biologic Products Holdings Inc.
• Takeda Pharmaceutical Company Limited
• Baxter International Inc.
• Kedrion SpA
• LFB SA
• Emergent BioSolutions Inc.
• Reliance Life Sciences Private Limited
• ADMA Biologics Inc.
• Prothya Biosolutions BV
• Bio Products Laboratory Ltd.
• Biotest AG
• Taibang Biological Group Co Ltd
• Octapharma Plasma Inc.
• New York Blood Center
• Green Cross Corporation
• China National Biotec Group Company Limited
• Kamada Ltd.
• Australian Red Cross Lifeblood
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the plasma protein therapeutics market in 2024
